NASDAQ:TALK Talkspace (TALK) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free TALK Stock Alerts $3.14 +0.17 (+5.72%) (As of 04:38 PM ET) Add Compare Share Share Today's Range$2.95▼$3.1450-Day Range$2.22▼$3.7852-Week Range$0.74▼$3.92Volume1.41 million shsAverage Volume1.26 million shsMarket Capitalization$530.35 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Talkspace alerts: Email Address Talkspace MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside3.5% Downside$3.00 Price TargetShort InterestHealthy2.52% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.63Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.03) to $0.04 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.55 out of 5 starsMedical Sector866th out of 918 stocksHealth Services Industry10th out of 10 stocks 1.0 Analyst's Opinion Consensus RatingTalkspace has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageTalkspace has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.52% of the float of Talkspace has been sold short.Short Interest Ratio / Days to CoverTalkspace has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Talkspace has recently increased by 9.29%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldTalkspace does not currently pay a dividend.Dividend GrowthTalkspace does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TALK. Previous Next 3.7 News and Social Media Coverage News SentimentTalkspace has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Talkspace this week, compared to 2 articles on an average week.Search Interest15 people have searched for TALK on MarketBeat in the last 30 days. This is an increase of 7% compared to the previous 30 days.MarketBeat Follows81 people have added Talkspace to their MarketBeat watchlist in the last 30 days. This is an increase of 636% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Talkspace insiders have not sold or bought any company stock.Percentage Held by Insiders18.40% of the stock of Talkspace is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions57.37% of the stock of Talkspace is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Talkspace are expected to grow in the coming year, from ($0.03) to $0.04 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Talkspace is -25.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Talkspace is -25.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTalkspace has a P/B Ratio of 4.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Talkspace Stock (NASDAQ:TALK)Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.Read More TALK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TALK Stock News HeadlinesApril 18, 2024 | msn.comTalkspace, Inc. (TALK) Gains As Market Dips: What You Should KnowApril 17, 2024 | globenewswire.comTalkspace to Report First Quarter 2024 and Host Conference CallApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 16, 2024 | finance.yahoo.comValidation Institute Certifies Talkspace’s ROI Calculator, Enabling Employers to Better Measure the Impact of Offering Virtual Mental Health ServicesApril 16, 2024 | businesswire.comValidation Institute Certifies Talkspace's ROI Calculator, Enabling Employers to Better Measure the Impact of Offering Virtual Mental Health ServicesApril 13, 2024 | finance.yahoo.comTALK Oct 2024 6.000 putApril 8, 2024 | finance.yahoo.com15 Best Places to Retire in VermontApril 8, 2024 | msn.comMoms for Liberty requests information from Baltimore County schools on LGBTQ+ books, health classesApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 4, 2024 | msn.comObsessive Thinking & The Cause of this Mental MazeApril 2, 2024 | seekingalpha.comTalkspace: Effective Partnership Expansion With Breakeven In SightApril 2, 2024 | seekingalpha.comTalkspace: After Doubling, There's Still Room To RallyMarch 30, 2024 | msn.comIs It Safe to Take Ozempic if You Have Depression?March 28, 2024 | msn.comNYC and Talkspace roll out free virtual mental health therapy for teensMarch 25, 2024 | finance.yahoo.comAnalysts Expect Talkspace, Inc. (NASDAQ:TALK) To Breakeven SoonMarch 21, 2024 | investorplace.com7 Speculative Penny Stocks to Watch for Massive UpsideMarch 19, 2024 | finance.yahoo.comTalkspace Launches Health Collective to Further Expand Accessibility to Healthcare ServicesMarch 16, 2024 | finance.yahoo.comTALK Oct 2024 1.000 callMarch 16, 2024 | finance.yahoo.comTALK Jul 2024 0.500 callMarch 11, 2024 | msn.comI reviewed a smart ring designed just for women. Should you buy it?March 7, 2024 | marketwatch.comTalkspace Review 2024March 7, 2024 | prnewswire.comWheel Adds Three High-Impact Companies to Its Integrated Virtual Care Ecosystem, Delivering More Choice, Improved Access, and Affordability to PatientsFebruary 28, 2024 | investorplace.com7 Starter Under-$5 Stocks Every New Investor Should OwnFebruary 26, 2024 | globenewswire.comTalkspace to Present at the Barclays 26th Annual Global Healthcare ConferenceFebruary 26, 2024 | finance.yahoo.comTALK Mar 2024 1.500 callFebruary 24, 2024 | finance.yahoo.comTalkspace Full Year 2023 Earnings: Beats ExpectationsFebruary 24, 2024 | news.yahoo.comHero Journey Club wants to meet gamers’ mental health needs, just don’t call it therapySee More Headlines Receive TALK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Talkspace and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today4/19/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:TALK CUSIPN/A CIK1803901 Webwww.talkspace.com Phone212-284-7206FaxN/AEmployees472Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside+1.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,180,000.00 Net Margins-12.78% Pretax Margin-12.64% Return on Equity-16.06% Return on Assets-13.51% Debt Debt-to-Equity RatioN/A Current Ratio6.46 Quick Ratio6.46 Sales & Book Value Annual Sales$150.04 million Price / Sales3.34 Cash FlowN/A Price / Cash FlowN/A Book Value$0.71 per share Price / Book4.18Miscellaneous Outstanding Shares168,900,000Free Float137,826,000Market Cap$501.63 million OptionableOptionable Beta1.26 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Jon R. Cohen M.D. (Age 69)CEO & Director Comp: $950.38kMs. Jennifer Fulk (Age 47)Chief Financial Officer Comp: $1.17MMr. Gil Margolin (Age 46)Chief Technology Officer Comp: $1.16MMr. John Charles Reilly (Age 57)Executive VP of Government Relations, Chief Legal Officer & Corporate Secretary Comp: $619.93kMr. Michael LovellSenior Director of Investor RelationsJeannine FeyenDirector of CommunicationsMs. Katelyn Watson (Age 45)Chief Marketing Officer Ms. Andrea CooperChief People OfficerMs. Michaela YuleChief Strategy OfficerMs. Erin Boyd (Age 55)Chief Growth Officer of Payor More ExecutivesKey CompetitorsInnovAgeNASDAQ:INNVThe Pennant GroupNASDAQ:PNTGDocGoNASDAQ:DCGOGeneDxNASDAQ:WGSSharecareNASDAQ:SHCRView All CompetitorsInstitutional OwnershipCounterpoint Mutual Funds LLCBought 36,987 shares on 4/15/2024Ownership: 0.022%Vanguard Group Inc.Bought 60,395 shares on 3/11/2024Ownership: 3.471%Goldman Sachs Group Inc.Bought 123,738 shares on 3/1/2024Ownership: 4.962%GSA Capital Partners LLPBought 168,179 shares on 2/16/2024Ownership: 0.135%Prelude Capital Management LLCBought 18,700 shares on 2/15/2024Ownership: 0.011%View All Institutional Transactions TALK Stock Analysis - Frequently Asked Questions Should I buy or sell Talkspace stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Talkspace in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" TALK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TALK, but not buy additional shares or sell existing shares. View TALK analyst ratings or view top-rated stocks. What is Talkspace's stock price target for 2024? 1 Wall Street research analysts have issued 1 year target prices for Talkspace's stock. Their TALK share price targets range from $3.00 to $3.00. On average, they expect the company's share price to reach $3.00 in the next year. This suggests that the stock has a possible downside of 3.5%. View analysts price targets for TALK or view top-rated stocks among Wall Street analysts. How have TALK shares performed in 2024? Talkspace's stock was trading at $2.54 at the beginning of the year. Since then, TALK stock has increased by 22.4% and is now trading at $3.11. View the best growth stocks for 2024 here. When is Talkspace's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our TALK earnings forecast. How can I listen to Talkspace's earnings call? Talkspace will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. How were Talkspace's earnings last quarter? Talkspace, Inc. (NASDAQ:TALK) posted its quarterly earnings data on Thursday, February, 22nd. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.03. The firm earned $42.42 million during the quarter, compared to analysts' expectations of $38.30 million. Talkspace had a negative trailing twelve-month return on equity of 16.06% and a negative net margin of 12.78%. During the same period last year, the business posted ($0.08) EPS. What guidance has Talkspace issued on next quarter's earnings? Talkspace issued an update on its FY 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $185.0 million-$195.0 million, compared to the consensus revenue estimate of $182.0 million. Who are Talkspace's major shareholders? Talkspace's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Counterpoint Mutual Funds LLC (0.02%). Insiders that own company stock include Douglas L Braunstein, Gil Margolin, Hudson Executive Capital Lp and John Charles Reilly. View institutional ownership trends. How do I buy shares of Talkspace? Shares of TALK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TALK) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.